Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.

Fontaine MJ, Kuo J, Chen G, Galel SA, Miller E, Sequeira F, Viele M, Goodnough LT, Tyan DB.

Transfusion. 2011 Dec;51(12):2611-8. doi: 10.1111/j.1537-2995.2011.03194.x. Epub 2011 May 26.

PMID:
21615749
2.

C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.

Llorente S, Boix F, Eguia J, López M, Bosch A, Martinez H, Gonzalez MJ, López-Hernández R, Salgado G, Moya-Quiles MR, Campillo JA, García-Alonso AM, Minguela A, Jimeno L, Alvarez-López MR, Muro M.

Transplant Proc. 2012 Nov;44(9):2535-7. doi: 10.1016/j.transproceed.2012.09.084.

PMID:
23146446
3.

Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.

Chen G, Sequeira F, Tyan DB.

Hum Immunol. 2011 Oct;72(10):849-58. doi: 10.1016/j.humimm.2011.07.001. Epub 2011 Jul 18.

PMID:
21791230
4.

Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.

Zeevi A, Lunz J, Feingold B, Shullo M, Bermudez C, Teuteberg J, Webber S.

J Heart Lung Transplant. 2013 Jan;32(1):98-105. doi: 10.1016/j.healun.2012.09.021. Epub 2012 Nov 9.

5.

Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.

Jia Y, Li W, Liu N, Zhang K, Gong Z, Li D, Wang L, Wang D, Jing Y, Wang J, Shan X.

Transfus Med. 2014 Dec;24(6):406-10. doi: 10.1111/tme.12157. Epub 2014 Oct 19.

PMID:
25327352
6.

Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?

Crespo M, Torio A, Mas V, Redondo D, Pérez-Sáez MJ, Mir M, Faura A, Guerra R, Montes-Ares O, Checa MD, Pascual J.

Transpl Immunol. 2013 Dec;29(1-4):28-33. doi: 10.1016/j.trim.2013.07.002. Epub 2013 Jul 29.

PMID:
23907088
7.
8.

Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies.

Lachmann N, Todorova K, Schulze H, Schönemann C.

Transplantation. 2013 Mar 15;95(5):694-700. doi: 10.1097/TP.0b013e31827b3dc3.

PMID:
23354296
9.

Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).

Wiita AP, Nambiar A.

Transfusion. 2012 Oct;52(10):2146-54. doi: 10.1111/j.1537-2995.2012.03593.x. Epub 2012 Mar 12.

PMID:
23113654
10.

Determinants of C1q binding in the single antigen bead assay.

Schaub S, Hönger G, Koller MT, Liwski R, Amico P.

Transplantation. 2014 Aug 27;98(4):387-93. doi: 10.1097/TP.0000000000000203.

PMID:
24918611
11.
12.

Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study.

Pavenski K, Warkentin TE, Shen H, Liu Y, Heddle NM.

Transfusion. 2010 Jul;50(7):1552-60. doi: 10.1111/j.1537-2995.2010.02602.x. Epub 2010 Feb 26.

PMID:
20210928
13.
14.

C1q assay for the detection of complement fixing antibody to HLA antigens.

Chen G, Tyan DB.

Methods Mol Biol. 2013;1034:305-11. doi: 10.1007/978-1-62703-493-7_16.

PMID:
23775744
15.

HLA antibody specification using single-antigen beads--a technical solution for the prozone effect.

Schnaidt M, Weinstock C, Jurisic M, Schmid-Horch B, Ender A, Wernet D.

Transplantation. 2011 Sep 15;92(5):510-5. doi: 10.1097/TP.0b013e31822872dd.

PMID:
21869744
16.

[HLA and transfusion: new approaches with Luminex™ technology].

Giannoli C, Nguyen TK, Dubois V.

Transfus Clin Biol. 2011 Apr;18(2):218-23. doi: 10.1016/j.tracli.2011.01.004. Epub 2011 Mar 11. Review. French.

PMID:
21397543
17.

Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelets compatible for both ABO and HLA.

McVey M, Cserti-Gazdewich CM.

Transfus Med. 2010 Oct;20(5):346-53. doi: 10.1111/j.1365-3148.2010.01011.x.

PMID:
20492602
18.
19.

Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.

Taylor CJ, Kosmoliaptsis V, Martin J, Knighton G, Mallon D, Bradley JA, Peacock S.

Transplantation. 2016 Jul 1. [Epub ahead of print]

PMID:
27306532
20.

Intravenous gamma globulin decreases platelet-associated IgG and improves transfusion responses in platelet refractory states.

Zeigler ZR, Shadduck RK, Rosenfeld CS, Winkelstein A, Przepiorka D, Kiss JE, Duquesnoy RJ, Marrari M.

Am J Hematol. 1991 Sep;38(1):15-23.

PMID:
1716849

Supplemental Content

Support Center